Epclusa® Sofosbuvir/Velpatasvir 400 mg/100 mg for Hepatitis C Treatment
USAMP#46917131SKU: 61958220101Epclusa®
License Required
Product Spotlight
- Comprehensive HCV Antiviral Therapy: Combines Sofosbuvir and Velpatasvir for effective treatment.
- Film-Coated Tablets: Ensures ease of swallowing and optimal absorption.
- Full Course in One Bottle: Contains 28 tablets for a complete treatment cycle.
- Manufactured by Gilead Sciences Inc: A trusted name in antiviral medication production.
- Prescription Required: Consult your healthcare provider for advice and prescription.
